Founder and CXO at CoFormBio with advisory roles at SyntaxBio and Susan Wojcicki Foundation. Previously held positions at EQRx, Scipher Medicine, and Goodwin. Biotech industry builder with China expertise.

Ex-Palantir engineer who moved into healthcare business development, now co-founder and CEO of Link Mobile.

PhD in Pharmacology who previously conducted research at Harvard Medical School, now founder of Attention Labs AI.

Yale Professor and founder & CEO of CellType (YC W26), working on AI for drug discovery.

Former VP of Data and AI at OVHcloud, now co-founder and CEO of Blaxel, building AI infrastructure for the agentic world. Serial entrepreneur with a successful exit.

Building the future of healthcare at Nolla. Previously consultant at BCG. Wharton and UT Austin grad.

Building the clinical reasoning engine to close the gap between diagnosis and treatment at Latent.

Duke alum and co-founder of Real. Previously founded Endpoints News (243k subscribers) and invented FierceBiotech during a 47-year journalism career covering biotech and healthcare.

Building healthcare's most trusted interface at Hera.

Co-founder of Parker Institute for Cancer Immunotherapy and Related Sciences, working at the intersection of science and finance to advance cancer research and biotechnology.